What is Juvenile Idiopathic Arthritis?

Based on information from Mexican Institute of Social Security (IMSS) , Dr. Nadina Rubio, Founder of the ANER (Assistance to Children with Rheumatic Diseases), Monterrey, Nuevo Leon, ensures that one of the diseases rheumatic most frequent in childhood is the Juvenile Idiopathic Arthritis (JIA), since it can appear from 6 months of age to 16 years.

This condition is characterized by the appearance of pain and inflammation of the joints , such as hands, elbows, knees, and wrists. This disease occurs in one in every thousand children below the age of 16, and is controllable with a positive prognosis when it is diagnosed and treated on time.

Symptoms of JIA

  1. Observe their capacity for physical movement, since the joints become inflamed, hot and have pain when moving them
  2. The inflammation chronic causes anemia , but as soon as it is controlled it disappears
  3. You may have trouble walking, do not want to run and / or wake up numb
  4. If you wake up at night because of intense pain
  5. Shows lack of appetite
  6. It will be notorious the impact on their quality of life

The treatment for this disease with biological therapies have given very good results, including Humira (adalimumab), which has just been authorized in Mexico for use in the treatment of JIA. According to the specialist, JIA is a disease of unknown origin, it may come from genes or environmental factors such as viral or bacterial infections . There are several subtypes and therefore the correct diagnosis is very important, since from there the treatment is determined to indicates, otherwise, it can cause affections in its growth and development.

This disease is controllable when it diagnostic and try on time. This is why it is recommended that parents support their child as much as possible so that they feel supported, because their emotional state is affected as well as an adult.

Have you noticed any of these symptoms in your children?


Video Medicine: What is JIA? (Juvenile Idiopathic Arthritis) (April 2024).